Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GBIO |
---|---|---|
09:32 ET | 1182 | 1.32 |
09:35 ET | 144 | 1.32 |
09:42 ET | 200 | 1.3 |
10:02 ET | 111 | 1.335 |
10:04 ET | 907 | 1.395 |
10:06 ET | 107 | 1.3823 |
10:08 ET | 575 | 1.385 |
10:11 ET | 1022 | 1.375 |
10:15 ET | 429 | 1.38 |
10:22 ET | 3000 | 1.355 |
10:24 ET | 300 | 1.33 |
10:26 ET | 138 | 1.33 |
10:29 ET | 300 | 1.305 |
10:31 ET | 1502 | 1.3043 |
10:33 ET | 11606 | 1.3 |
10:36 ET | 4529 | 1.3 |
10:38 ET | 200 | 1.31 |
10:40 ET | 3545 | 1.315 |
10:42 ET | 240 | 1.31 |
10:44 ET | 7036 | 1.315 |
10:47 ET | 3000 | 1.3284 |
10:49 ET | 12500 | 1.35 |
10:51 ET | 19621 | 1.38 |
10:54 ET | 16349 | 1.3699 |
10:56 ET | 5831 | 1.37 |
10:58 ET | 1842 | 1.361 |
11:00 ET | 400 | 1.37 |
11:02 ET | 2199 | 1.373 |
11:03 ET | 21568 | 1.4 |
11:05 ET | 895 | 1.39 |
11:09 ET | 1032 | 1.39 |
11:12 ET | 100 | 1.39 |
11:14 ET | 11204 | 1.42 |
11:16 ET | 1000 | 1.42 |
11:18 ET | 10650 | 1.4116 |
11:20 ET | 300 | 1.425 |
11:21 ET | 2500 | 1.42 |
11:23 ET | 1925 | 1.42 |
11:25 ET | 200 | 1.42 |
11:30 ET | 120 | 1.415 |
11:36 ET | 1296 | 1.43 |
11:38 ET | 1200 | 1.43 |
11:41 ET | 100 | 1.43 |
11:43 ET | 2709 | 1.42 |
11:45 ET | 595 | 1.421 |
11:50 ET | 100 | 1.43 |
11:52 ET | 110 | 1.4299 |
11:54 ET | 200 | 1.42 |
11:56 ET | 500 | 1.42 |
11:59 ET | 128 | 1.425 |
12:01 ET | 300 | 1.425 |
12:06 ET | 3537 | 1.44 |
12:12 ET | 100 | 1.44 |
12:15 ET | 1036 | 1.44 |
12:17 ET | 138 | 1.44 |
12:21 ET | 3500 | 1.45 |
12:26 ET | 500 | 1.4698 |
12:28 ET | 4156 | 1.47 |
12:30 ET | 100 | 1.48 |
12:32 ET | 600 | 1.475 |
12:35 ET | 2107 | 1.465 |
12:42 ET | 2050 | 1.44 |
12:48 ET | 3000 | 1.44 |
12:51 ET | 500 | 1.44 |
12:53 ET | 2394 | 1.43 |
01:00 ET | 1000 | 1.4286 |
01:09 ET | 2008 | 1.41 |
01:11 ET | 935 | 1.41 |
01:13 ET | 645 | 1.41 |
01:15 ET | 200 | 1.41 |
01:18 ET | 437 | 1.41 |
01:26 ET | 100 | 1.41 |
01:27 ET | 850 | 1.4018 |
01:31 ET | 100 | 1.4 |
01:33 ET | 400 | 1.41 |
01:36 ET | 170 | 1.4134 |
01:38 ET | 1159 | 1.4008 |
01:40 ET | 563 | 1.41 |
01:42 ET | 200 | 1.4 |
01:45 ET | 6545 | 1.39 |
01:47 ET | 200 | 1.38 |
01:49 ET | 4400 | 1.365 |
01:51 ET | 100 | 1.37 |
01:56 ET | 108 | 1.37 |
02:00 ET | 1950 | 1.375 |
02:02 ET | 1607 | 1.3733 |
02:07 ET | 145 | 1.3798 |
02:09 ET | 1500 | 1.375 |
02:12 ET | 2114 | 1.38 |
02:14 ET | 1283 | 1.39 |
02:18 ET | 100 | 1.39 |
02:20 ET | 350 | 1.39 |
02:23 ET | 100 | 1.39 |
02:25 ET | 1211 | 1.39 |
02:30 ET | 200 | 1.395 |
02:34 ET | 525 | 1.395 |
02:36 ET | 600 | 1.395 |
02:38 ET | 2229 | 1.4 |
02:39 ET | 239 | 1.4 |
02:41 ET | 366 | 1.4 |
02:43 ET | 769 | 1.38 |
02:45 ET | 800 | 1.37 |
02:52 ET | 100 | 1.36 |
02:54 ET | 100 | 1.37 |
02:56 ET | 464 | 1.38 |
02:57 ET | 109 | 1.375 |
03:01 ET | 6800 | 1.36 |
03:03 ET | 100 | 1.36 |
03:06 ET | 1066 | 1.36 |
03:08 ET | 2100 | 1.36 |
03:10 ET | 100 | 1.36 |
03:12 ET | 151 | 1.36 |
03:15 ET | 1600 | 1.36 |
03:17 ET | 508 | 1.36 |
03:19 ET | 100 | 1.36 |
03:21 ET | 1057 | 1.35 |
03:24 ET | 8724 | 1.345 |
03:26 ET | 1405 | 1.345 |
03:28 ET | 250 | 1.3422 |
03:30 ET | 400 | 1.34 |
03:32 ET | 1100 | 1.35 |
03:33 ET | 4050 | 1.3599 |
03:35 ET | 300 | 1.355 |
03:37 ET | 200 | 1.355 |
03:39 ET | 400 | 1.35 |
03:42 ET | 3717 | 1.36 |
03:44 ET | 200 | 1.36 |
03:46 ET | 100 | 1.37 |
03:48 ET | 3130 | 1.365 |
03:50 ET | 441 | 1.37 |
03:51 ET | 1700 | 1.3699 |
03:53 ET | 100 | 1.365 |
03:55 ET | 3603 | 1.375 |
03:57 ET | 3673 | 1.37 |
04:00 ET | 30583 | 1.37 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Generation Bio Co | 91.5M | -0.6x | --- |
Adlai Nortye Ltd | 97.0M | -0.4x | --- |
Assembly Biosciences Inc | 95.6M | -2.0x | --- |
Coya Therapeutics Inc | 108.6M | -9.4x | --- |
Armata Pharmaceuticals Inc | 81.4M | -1.8x | --- |
CervoMed Inc | 79.2M | -6.0x | --- |
Generation Bio Co. is a biotechnology company. The Company is innovating non-viral genetic medicines to provide durable, redosable treatments for hundreds of millions of patients living with rare and prevalent diseases. The Company is developing two distinct and complementary platforms: a potent, highly selective cell-targeted lipid nanoparticle (ctLNP) delivery system and a novel immune-quiet DNA (iqDNA) cargo produced by a scalable capsid-free manufacturing process that uses proprietary cell-free rapid enzymatic synthesis (RES). The Company is advancing a portfolio of programs guided by the potent and highly selective delivery of messenger ribonucleic acid (mRNA) and/or iqDNA using its ctLNP delivery system to target T cells, hematopoietic stem cells (HSCs), and hepatocytes, and intend to expand to additional tissues and cell types. Its work in T cells focuses on in vivo reprogramming of this cell type to treat cancer and autoimmune diseases.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $91.5M |
---|---|
Revenue (TTM) | $18.6M |
Shares Outstanding | 66.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.69 |
EPS | $-2.19 |
Book Value | $3.07 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | 4.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -846.24% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.